FAQ
-
Yes, Motiva Implants®* are FDA approved with less than 1% device related-complications¹.
Reference:
(1) Glicksman C, Wolfe A, McGuire P, The Study of the Safety and Effectiveness of Motiva SmoothSilk Silicone Gel-Filled Breast Implants in Patients Undergoing Primary and Revisional Breast Augmentation: Three-Year Clinical Data. Aesthet Surg J. 2024 sjae134, doi.org/10.1093/asj/sjae138Disclaimer:
Learn more
*Motiva SmoothSilk® Round and Motiva SmoothSilk Ergonomix® implants have received Premarket Approval (PMA) from the Food and Drug Administration (FDA) for Augmentation Indication, and are commercially available in the US.
Motiva Implants® for Reconstruction Indication are not yet commercially available in the US and are undergoing clinical investigation pursuant to FDA regulations for investigational medical devices. -
We manufacture Motiva Implants, but we don’t do any surgeries.
Surgeons from all over the world are using our implants. Here's a link to our Center locator, where certified surgeons who use Motiva Implants are listed in your requested region: https://motiva.health/app/center-locator/.
We suggest that you make an appointment with one or more of them to discuss the desired result and Motiva options.
Learn more -
Qid® is the world’s first microtransponder for clinical use in a breast implant. It is the only transponder with a CE mark (which indicates compliance with the health, safety, and environmental protection standards for products sold in the European Economic Area), and the United States Food & Drug Administration (FDA) cleared it for use in 2004. Qid® is placed in the gel filling inside Motiva® Implants.
A handheld reader is used to externally scan the transponder, providing an electronic serial number (ESN) that can be used to retrieve important implant information such as manufacturing date, implant type, volume, and more.
Qid® is an optional feature in Motiva® Implants that is particularly useful to patients and surgeons to identify the implant type after the surgery, and to verify implant details during the event of a product recall.
Product information or warranty on cards can be lost or misplaced. With its unique ESN permanently located within the breast implant, Qid® provides the confidence of instant implant traceability and verification.
A radio frequency identification (RFID) microtransponder (Qid®) is a passive component (without a battery) placed in the gel that provides each implant device with a unique electronic serial number which is only accessible through the use of a handheld scanner specific to Motiva. The Electronic serial number does not contain patient-specific or identifiable information, only device-specific information such as the manufacturing date, serial number, lot number, implant volume, size and projection, model and surface type).
The Qid is 9mm in length.
The components of the Qid® are:
- Copper Polystermide Estersol 180 wire,
- Nickel-Zinc Ferrite core,
- Photobond4442 Acrylate adhesive,
- 4305 Application Specific Integrated Circuit (ASIC),
- and Soda-lime Silicate glass.
Learn more
-
The American Academy of Pediatrics has stated that there is no reason why a woman with implants should refrain from nursing. However, breast implant surgery may interfere with how optimal breastfeeding may be, either by reducing or eliminating milk production.
Most women with breast implants who attempt nursing have successfully breastfed their babies. It is not known if there are increased risks for a woman with breast implants or if the children of women with breast implants are more likely to have health problems.
Please inform your surgeon in advance of your procedure if you wish to have the option to breastfeed afterwards, as a surgical approach with this consideration may reduce the chance of breastfeeding difficulties.
Learn more -
The microtransponder (Qid®) is MRI-safe. The device is “MRI conditional”, meaning that it has been demonstrated to pose no known hazards in a specified MRI environment with specified conditions of use.
Qid® may create an imaging void during MRI (known as an artifact effect) that can block visualization of a small area of minor breast tissue near it. In special cases, alternative imaging techniques such as ultrasound, tomosynthesis, digital compression mammography, subtraction contrast mammography, and/or scintimammography can be used to better visualize the region obstructed by Qid®.
For more information, please refer to the attached documents 'Qid facts for surgeons and radiologists'.
Learn more